Glenmark Pharmaceuticals has informed that it attached a media release titled ‘Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)’.
The above information is a part of company’s filings submitted to BSE.